Apr 17, 2020 / 12:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Moderna's conference call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Ms. Lavina Talukdar. Please go ahead, ma'am.
Lavina Talukdar - Moderna, Inc. - Head of IR
Thank you, operator. Good morning, and welcome to Moderna's conference call. Today, we will discuss the award from the Biomedical Advanced Research and Development Authority, or BARDA, to accelerate the development of mRNA-1273, our vaccine against the novel coronavirus. You can access the press release issued yesterday evening by going to the Investors section of our website.
Today on this call, we have Stéphane Bancel, Chief Executive Officer; Stephen Hoge, President; Tal Zaks, Chief Medical Officer; Juan Andres, Chief Technical Operations and Quality Officer; and Lorence Kim, Chief Financial Officer.
Before we begin, please note that this conference call will include forward-looking statements. Please see our SEC filings for important risk factors that could
Moderna, Inc. - Award from U.S. Government Agency BARDA to Accelerate Development of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus Transcript
Apr 17, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers